People channel feed – Endpoints News

People channel feed

Amgen's Bob Bradway takes slight salary dip amid higher pay among US execs

3 years ago

Biogen lays off more employees after reducing headcount last year

3 years ago

Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers — including CEO

3 years ago

Peptide manufacturer Mytide Therapeutics names Martina Diekmann as CEO

3 years ago

Takeda ending discovery, preclinical work in AAV gene therapy, rare hematology

3 years ago

Cell therapy biotech Sernova responds to board nominees from 'concerned shareholders'

3 years ago

Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale

3 years ago

Hedge fund slams Exelixis for R&D management, launches proxy fight for board seats (updated)

3 years ago

PureTech wants to buy back its weight loss pill spinout after lackluster SPAC

3 years ago

'Have to keep up this pace': As new Vir CEO, Marianne De Backer eyes expansion beyond infectious disease

3 years ago

Following clinical setbacks, NGM Bio lays off 33% of staffers as founder departs

3 years ago

Thermo Fisher set to shutter a site in New Jersey, lay off 100+ people

3 years ago

As market stays cold, biotechs continue to cut programs, trials and staff

3 years ago

Biogen appoints Adam Keeney to run business development activities

3 years ago

Vedere Bio II, gene therapy biotech born out of Novartis buyout, closes down

3 years ago

Sarissa tightens its grip on Amarin as CEO resigns

3 years ago

TCR upstart announces CEO exit, with CSO now acting replacement

3 years ago

Austin biotech Molecular Templates lays off more than 100 staffers as pipeline narrows

3 years ago

Aptinyx evaluates future of the company following two failed trials, 60% layoffs

3 years ago

Galapagos sends some employees — and a research unit — off to drug discovery CRO as part of reorg

3 years ago

Alector cuts 11% of workforce as it doubles down on late-stage neuro programs partnered with GSK, AbbVie

3 years ago

Mathai Mammen hands in J&J's R&D keys to lead Greg Verdine’s FogPharma

3 years ago

Q&A: Newly-minted CSL chief executive Paul McKenzie and chief medical officer Bill Mezzanotte

3 years ago

Layoffs hit private gene therapy startups, migraine biotech Satsuma as industry squeeze doesn’t let up

3 years ago

First page Previous page 28 29 303132 33 34 Next page Last page